Curio Digital Therapeutics
PrivateLast Round
Series A
Aug 28, 2024
Total Funding Raised
$10.08M
Company Overview
Curio Digital Therapeutics, Inc. is a digital health company that develops prescription digital therapeutics solutions and interventions for women's behavioral health.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Telemedicine, Medical AI, Patient Engagement
Business Model
B2B2C
Customer Profile
Subscription SaaS, Government Contracts, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Curio Digital Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Curio Digital Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 28, 2024 | ||||
| Grant | Feb 1, 2023 |
Curio Digital Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ONCE Ventures | Series A |
| New Jersey Commission on Science, Innovation and Technology | Grant |
| Bridge Point Capital | Series A |
| Avestria Ventures | Series A, Seed |
| Springboard Enterprises | Accelerator |
| RYSE Asset Management | Series A |
Curio Digital Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Curio Digital Therapeutics's valuation, stock price, and market status.